Browse All

Current Filters

CLEAR FILTER x

TITLE

Safety and Efficacy of Inebilizumab in AQP4+ NMOSD Participants with History of Immunosuppression Treatment Prior to N-MOmentum Study

Author:Paul, Friedemann   Marignier, Roman   Lindsey, John   Kim, Ho Jin   She, Dewei   Cimbora, Daniel   Patterson, Kristina   Cree, Bruce   

Session Name:P13: Autoimmune Neurology: NMOSD / MOGAD / Optic Neuritis  

Topic:Autoimmune Neurology  

Program Number:P13.003  

Author Institution:Charite Universitatsmedizin in Berlin, Berlin, Germany  Hospices Civils de Lyon, Lyon, France  University of Texas Health Science Center at Houston, Houston, TX  National Cancer Center, Goyang, Korea, Republic of  Horizon Therapeutics plc, Gaithersburg, MD  Horizon Therapeutics plc, Deerfield, IL  UCSF, Multiple Sclerosis Center, San Francisco, CA  

A Qualitative Analysis of Transition from Pediatric to Adult Care for Patients with Autism and Intellectual Disabilities

Author:Carter, Sydney   Chambers, Jalon   

Session Name:P13: Child Neurology and Developmental Neurology: Cerebral Palsy/Autism Spectrum Disorder/Neurodevelopmental Disorders  

Topic:Child Neurology and Developmental Neurology  

Program Number:P13.010  

Author Institution:University of Texas Southwestern Medical School, Dallas, TX  University of Texas Health Science Center at Houston, Houston, TX